Abstract
In a study on 138 hypertensive non-insulin dependent diabetic subjects, factors influencing lipoproteins were assessed. Multiple regression analyses were carried out in order to assess the influence of beta-blocker antihypertensive therapy while making allowances for other confounding variables. In males, but not in females, on a beta-blocker for hypertension, total high density lipoprotein- (HDL-) and HDL-subfraction cholesterol were significantly lower while the serum triglyceride was increased, though not significantly. In male non-insulin dependent diabetics, regimens containing a beta-blocker may worsen an already abnormal lipoprotein profile and antihypertensive agents other than beta-blocking agents should be used if possible.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dodson P. M., Horton R. C. The hypertension of diabetes mellitus: mechanisms and implications. J Hum Hypertens. 1988 Mar;1(4):241–247. [PubMed] [Google Scholar]
- Eder H. A., Gidez L. I. The clinical significance of the plasma high density lipoproteins. Med Clin North Am. 1982 Mar;66(2):431–440. doi: 10.1016/s0025-7125(16)31428-6. [DOI] [PubMed] [Google Scholar]
- Eisenberg S. High density lipoprotein metabolism. J Lipid Res. 1984 Oct;25(10):1017–1058. [PubMed] [Google Scholar]
- Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
- Haskell W. L., Camargo C., Jr, Williams P. T., Vranizan K. M., Krauss R. M., Lindgren F. T., Wood P. D. The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. A controlled study. N Engl J Med. 1984 Mar 29;310(13):805–810. doi: 10.1056/NEJM198403293101301. [DOI] [PubMed] [Google Scholar]
- Kannel W. B., McGee D. L. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979 Jan;59(1):8–13. doi: 10.1161/01.cir.59.1.8. [DOI] [PubMed] [Google Scholar]
- Krauss R. M. Regulation of high density lipoprotein levels. Med Clin North Am. 1982 Mar;66(2):403–430. doi: 10.1016/s0025-7125(16)31427-4. [DOI] [PubMed] [Google Scholar]
- Laakso M., Voutilainen E., Sarlund H., Aro A., Pyörälä K., Penttilä I. Inverse relationship of serum HDL and HDL2 cholesterol to C-peptide level in middle-aged insulin-treated diabetics. Metabolism. 1985 Aug;34(8):715–720. doi: 10.1016/0026-0495(85)90020-4. [DOI] [PubMed] [Google Scholar]
- Lehtonen A. Effects of beta-blockers on plasma lipids during antihypertensive therapy. J Cardiovasc Pharmacol. 1985;7 (Suppl 2):S110–S114. doi: 10.1097/00005344-198507002-00021. [DOI] [PubMed] [Google Scholar]
- Richmond W., Seviour P. W., Teal T. K., Elkeles R. S. Impaired intravascular lipolysis with changes in concentrations of high density lipoprotein subclasses in young smokers. Br Med J (Clin Res Ed) 1987 Jul 25;295(6592):246–247. doi: 10.1136/bmj.295.6592.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sacks F. M., Dzau V. J. Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action. Am J Med. 1986 Feb 14;80(2A):71–81. doi: 10.1016/0002-9343(86)90163-4. [DOI] [PubMed] [Google Scholar]
- Seviour P. W., Elkeles R. S. High density lipoproteins, diabetes and diabetic macrovascular disease. Diabet Med. 1985 Sep;2(5):348–351. doi: 10.1111/j.1464-5491.1985.tb00648.x. [DOI] [PubMed] [Google Scholar]
- Tyroler H. A. Review of lipid-lowering clinical trials in relation to observational epidemiologic studies. Circulation. 1987 Sep;76(3):515–522. doi: 10.1161/01.cir.76.3.515. [DOI] [PubMed] [Google Scholar]
- Warnick G. R., Benderson J., Albers J. J. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982 Jun;28(6):1379–1388. [PubMed] [Google Scholar]